HOME >> MEDICINE >> NEWS
Smoking increases risk for liver, pancreatic and colorectal cancers

CHICAGO, IL (May 17, 2005) Smoking may have a devastating effect on gastrointestinal health and increase a person's risk of developing pancreatic and liver cancer, according to new research presented today at Digestive Disease Week 2005 (DDW). Furthermore, data from the Nurses' Health Study shows that meat intake and smoking play a part in significantly increasing a woman's risk of colorectal cancer. DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

"The effects of smoking on the respiratory system are well known and well documented through research," said Lee Kaplan, M.D., Ph.D., of Massachusetts General Hospital. "Recognizing that this high-risk behavior also hurts the digestive system is fundamental in preventing life-threatening cancers and improving overall health."

Smoking and Alcohol Use Associated with Markedly Earlier Age of Onset in Pancreatic Adenocarcinoma (Abstract 360)

With the link between smoking and pancreatic adenocarcinoma established, researchers from Evanston Northwestern Healthcare, an academic health system affiliated with Northwestern University, investigated the impact of smoking and alcohol use on the age of pancreatic cancer diagnosis and found that both play significant roles in the early onset of the disease.

Patients who were currently alcohol and tobacco users were diagnosed an average of 13 years earlier than individuals who had never used alcohol or tobacco, at median ages of 61 and 74 respectively for initial diagnosis. The data shows that smoking may have a more profound negative effect on the pancreas than alcohol, with current tobacco users being consistently diagnosed earlier than individuals who were current or former alcohol users. Study results also indicate that smoking and alcohol use may have a long-term effect on the pancreas, even after cessation. Indivi
'"/>


17-May-2005


Page: 1 2 3 4

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Smoking may interfere with alcoholics neurocognitive recovery during abstinence
3. Smoking rate has plummeted in New York City
4. Smoking and sleep top the list of lifestyle factors impacting oral health
5. Smoking, growing private hospital care for poor and US flu vaccine policies
6. Smoking influences Crohns disease
7. Smoking ban dramatically reduces air pollution in Irish pubs
8. Smoking may be a risk factor for tuberculosis
9. Smoking increases risk of TB infection, says new study
10. Smoking worsens knee osteoarthritis
11. Smoking cessation therapy may be harmful for ICU patients

Post Your Comments:
(Date:6/19/2013)... (PRWEB) June 19, 2013 Blueforce ... and sensor machine software, today announced it has ... its Decentralized Fusion Engine technology. The award ... the acquisition of key strategic partnerships. , ... wireless collaboration and machine-to-machine (M2M) software products that ...
(Date:6/19/2013)... A blow to the head; a swift jarring to ... to hours. It’s understandable, but what else may follow ... traumatic brain injury. According to mayoclinic.com , usual ... But many other symptoms may follow, sometimes not for ... include ongoing headaches, dizziness, feeling like you’re in a fog, ...
(Date:6/19/2013)... 19, 2013 Walkingspree, a specialized wellness ... the launch of its new Facebook App. This is ... inspire participants to reach their program fitness goals. Consistent ... Walkingspree clients are given more tools to customize their ... , Corporate clients may choose whether or not they ...
(Date:6/19/2013)... Weight gain and obesity have been ... including heart disease, kidney failure and high blood pressure. ... and unnecessary fat, have many people searching for fast ... diets to not only allow patients to succeed ... aim to reduce the risk for many weight-related health ...
(Date:6/19/2013)... June 19, 2013 The reason for the ... because users can place a 4x8 flood tray inside the ... to work around. In addition, Gorilla Grow Tents are ... are the tallest, thickest and strongest grow tents on the ... grow tent standards. , Gorilla Grow Tents are ...
Breaking Medicine News(10 mins):Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Stealth Grow Tent Brand’s Popularity Rises 2
(Date:6/18/2013)... 2013 , Safinamide significantly ... patients as add-on to levodopa Safinamide ... symptoms in fluctuating PD patients as add-on to ... S.p.A. ("Newron"), a research and development company focused ... partner Zambon S.p.A., a pharmaceutical company strongly committed ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... public offering of common shares (the "Offering"). Pursuant to ... at a price of $85.00 per share, for aggregate ... file a final prospectus supplement to its effective shelf ... similar filing with the securities regulatory authorities in each ...
(Date:6/18/2013)... , June 18, 2013  It has ... of Alliance Seating and Mobility, a subsidiary company ... access timely repair. This appears to be due ... reduction of field service employees.  ... great many of these clients are complex mobility ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
Cached News: